WILSON TROY EDWARD
Insider CIK 1589597 · PBYI Director · KURA President and CEO, Director, 10% owner · ZSAN Director · RNA Director · RNA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2026-09-14 | 2026-09-16 | 5,000 | $9.10 | $45.5K | 54,750 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2026-09-14 | 2026-09-16 | 5,000 | $9.10 | $45.5K | 54,750 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2026-08-24 | 2026-08-24 | 100,000 | $12.39 | $1.24M | 479,194 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2026-08-24 | 2026-08-24 | 100,000 | $12.39 | $1.24M | 479,194 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2026-08-17 | 2026-08-17 | 100,000 | $11.12 | $1.11M | 379,194 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2026-08-17 | 2026-08-17 | 100,000 | $11.12 | $1.11M | 379,194 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2026-06-12 | 2026-06-15 | 10,800 | $7.20 | $77.8K | 59,750 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2026-06-11 | 2026-06-15 | 27,000 | — | $0 | 70,550 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2026-03-23 | 2026-03-25 | 6,103 | — | $0 | 0 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2026-03-23 | 2026-03-25 | 6,103 | $6.15 | $37.5K | 435,456 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 13,489 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 15,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 10,034 | — | $0 | 0 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | A Award deriv | 2026-02-27 | 2026-03-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 13,711 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 65,091 | — | $0 | 0 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 1,120,000 | — | $0 | 1,120,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award | 2025-11-13 | 2025-11-14 | 182,500 | — | $0 | 429,353 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2025-09-29 | 2025-09-29 | 36,615 | $8.94 | $327.3K | 246,853 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award | 2025-09-27 | 2025-09-29 | 182,500 | — | $0 | 283,468 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2025-09-08 | 2025-09-09 | 50,000 | $8.20 | $410.0K | 100,968 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-09-05 | 2025-09-09 | 14,500 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-09-05 | 2025-09-09 | 14,500 | $50.00 | $725.0K | 69,425 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-09-05 | 2025-09-09 | 15,000 | $50.00 | $750.0K | 54,425 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-09-05 | 2025-09-09 | 14,500 | $12.48 | $181.0K | 83,925 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2025-08-13 | 2025-08-14 | 13,494 | $6.64 | $89.6K | 50,968 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2025-08-12 | 2025-08-14 | 36,506 | $5.85 | $213.6K | 37,474 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-06 | 2025-08-08 | 22,000 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-06 | 2025-08-08 | 7,500 | — | $0 | 14,500 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 17,777 | $45.00 | $800.0K | 17,776 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-06 | 2025-08-08 | 22,000 | $12.03 | $264.7K | 91,425 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 17,777 | $45.00 | $800.0K | 17,776 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 22,000 | $45.00 | $990.0K | 69,425 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-06 | 2025-08-08 | 7,500 | $12.48 | $93.6K | 76,925 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 7,500 | $45.00 | $337.5K | 69,425 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 15,000 | $45.00 | $675.0K | 285,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 15,000 | $45.00 | $675.0K | 285,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2025-06-13 | 2025-06-17 | 10,800 | $3.40 | $36.7K | 43,550 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2025-06-11 | 2025-06-13 | 27,000 | — | $0 | 54,350 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 69,425 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 625,000 | — | $0 | 625,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2024-06-18 | 2024-06-21 | 27,000 | — | $0 | 27,350 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 13,489 | — | $0 | 13,489 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2024-06-13 | 2024-06-17 | 27,000 | $3.33 | $89.9K | 350 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2024-01-24 | 2024-01-26 | 84,107 | $20.23 | $1.70M | 559 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2024-01-24 | 2024-01-26 | 6,945 | $4.80 | $33.3K | 7,504 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2024-01-24 | 2024-01-26 | 6,945 | $20.23 | $140.5K | 559 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2024-01-24 | 2024-01-26 | 84,107 | $6.15 | $517.3K | 84,666 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 560,000 | — | $0 | 560,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | J Other | 2023-12-12 | 2023-12-14 | 250,000 | — | $0 | 300,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | J Other | 2023-12-12 | 2023-12-14 | 250,000 | — | $0 | 13,711 | SEC↗ |
| RNA Avidity Biosciences, Inc. | J Other | 2023-12-12 | 2023-12-14 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | J Other | 2023-12-12 | 2023-12-14 | 300,000 | — | $0 | 263,711 | SEC↗ |
| KURA Kura Oncology, Inc. | G Gift | 2023-12-07 | 2023-12-11 | 2,000 | — | $0 | 559 | SEC↗ |
| KURA Kura Oncology, Inc. | G Gift | 2023-12-07 | 2023-12-11 | 1,000 | — | $0 | 279,194 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2023-06-13 | 2023-06-15 | 27,000 | $3.45 | $93.2K | 350 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2023-06-13 | 2023-06-15 | 27,000 | — | $0 | 27,350 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2023-06-02 | 2023-06-02 | 8,394 | — | $0 | 0 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2023-06-02 | 2023-06-02 | 300,000 | — | $0 | 300,000 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2023-06-02 | 2023-06-02 | 8,394 | — | $0 | 1,134,012 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2023-06-02 | 2023-06-02 | 41,318 | — | $0 | 1,092,694 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2023-06-02 | 2023-06-02 | 212,500 | — | $0 | 880,194 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2023-06-02 | 2023-06-02 | 27,966 | — | $0 | 2,559 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2023-06-02 | 2023-06-02 | 300,000 | — | $0 | 280,194 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2023-06-02 | 2023-06-02 | 300,000 | — | $0 | 580,194 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2023-02-16 | 2023-02-21 | 560,000 | — | $0 | 560,000 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2022-10-06 | 2023-02-21 | 1,084,300 | — | $0 | 8,394 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2022-10-06 | 2023-02-21 | 1,084,300 | — | $0 | 1,125,618 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2022-08-19 | 2023-02-21 | 17,708 | — | $0 | 1,134,012 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2022-08-19 | 2023-02-21 | 41,318 | — | $0 | 41,318 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2022-08-19 | 2023-02-21 | 11,985 | — | $0 | 30,525 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2022-08-19 | 2023-02-21 | 41,318 | — | $0 | 1,092,694 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2022-07-14 | 2023-02-21 | 468,297 | — | $0 | 1,151,720 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2022-06-16 | 2022-06-21 | 27,858 | $2.58 | $71.9K | 27,350 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2022-06-14 | 2022-06-16 | 27,000 | — | $0 | 55,208 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2022-01-26 | 2022-01-28 | 495,000 | — | $0 | 495,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2021-06-16 | 2021-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2021-06-15 | 2021-06-17 | 27,858 | — | $0 | 28,208 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2021-06-10 | 2021-06-11 | 25,748 | $11.36 | $292.5K | 350 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 366,500 | — | $0 | 366,500 | SEC↗ |
| KURA Kura Oncology, Inc. | J Other | 2020-12-23 | 2021-01-28 | 175,000 | — | $0 | 1,620,017 | SEC↗ |
| RNA Avidity Biosciences, Inc. | J Other | 2020-12-22 | 2020-12-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | J Other | 2020-12-22 | 2020-12-28 | 100,000 | — | $0 | 89,618 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-12-01 | 2020-12-02 | 11,855 | — | $0 | 90,210 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-12-01 | 2020-12-02 | 11,855 | $6.15 | $72.9K | 39,951 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-10-08 | 2020-10-08 | 50,370 | — | $0 | 102,065 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-10-08 | 2020-10-08 | 50,370 | $34.00 | $1.71M | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-10-08 | 2020-10-08 | 50,370 | $6.15 | $309.8K | 78,466 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-10-08 | 2020-10-08 | 106,736 | $34.00 | $3.63M | 0 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-10-07 | 2020-10-08 | 4,586 | — | $0 | 152,435 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-10-07 | 2020-10-08 | 4,586 | $34.00 | $155.9K | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-10-07 | 2020-10-08 | 4,586 | $6.15 | $28.2K | 32,682 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-10-07 | 2020-10-08 | 99,900 | $32.00 | $3.20M | 106,736 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-10-06 | 2020-10-08 | 100 | $32.00 | $3.2K | 206,636 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-09-14 | 2020-09-15 | 98,490 | $28.82 | $2.84M | 206,736 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-09-11 | 2020-09-15 | 17,926 | — | $0 | 157,021 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-09-11 | 2020-09-15 | 485 | $28.00 | $13.6K | 305,226 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-09-11 | 2020-09-15 | 17,926 | $28.00 | $501.9K | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-09-11 | 2020-09-15 | 17,926 | $6.15 | $110.2K | 46,022 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-09-10 | 2020-09-10 | 37,030 | — | $0 | 174,947 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-09-10 | 2020-09-10 | 37,030 | $28.00 | $1.04M | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-09-10 | 2020-09-10 | 37,030 | $6.15 | $227.7K | 65,126 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-09-10 | 2020-09-10 | 1,025 | $28.00 | $28.7K | 305,711 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-09-08 | 2020-09-10 | 50,000 | $26.00 | $1.30M | 306,736 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-08-25 | 2020-08-26 | 22,838 | — | $0 | 211,977 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-08-25 | 2020-08-26 | 215 | — | $0 | 6,945 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-08-25 | 2020-08-26 | 22,838 | $6.15 | $140.5K | 50,934 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-08-25 | 2020-08-26 | 215 | $4.80 | $1.0K | 51,149 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-08-25 | 2020-08-26 | 23,053 | $22.37 | $515.7K | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-08-24 | 2020-08-26 | 6,568 | — | $0 | 7,160 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-08-24 | 2020-08-26 | 6,568 | $22.04 | $144.8K | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-08-24 | 2020-08-26 | 6,568 | $4.80 | $31.5K | 34,664 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-08-19 | 2020-08-19 | 11,913 | — | $0 | 13,728 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-08-19 | 2020-08-19 | 11,913 | $4.80 | $57.2K | 40,009 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-08-19 | 2020-08-19 | 11,913 | $22.09 | $263.2K | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-08-18 | 2020-08-19 | 521 | — | $0 | 25,641 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-08-18 | 2020-08-19 | 521 | $22.00 | $11.5K | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-08-18 | 2020-08-19 | 521 | $4.80 | $2.5K | 28,617 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-08-17 | 2020-08-19 | 12,901 | — | $0 | 26,162 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-08-17 | 2020-08-19 | 12,901 | $22.00 | $283.8K | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-08-17 | 2020-08-19 | 12,901 | $4.80 | $61.9K | 40,997 | SEC↗ |
| KURA Kura Oncology, Inc. | G Gift | 2020-08-17 | 2020-08-19 | 26,041 | — | $0 | 1,795,017 | SEC↗ |
| KURA Kura Oncology, Inc. | G Gift | 2020-08-17 | 2020-08-19 | 26,041 | — | $0 | 28,096 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2020-08-17 | 2020-08-19 | 50,000 | $22.00 | $1.10M | 356,736 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 254,907 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 108,504 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 35,374 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 189,042 | — | $0 | 805,301 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2020-06-11 | 2020-06-15 | 25,245 | $9.97 | $251.7K | 26,098 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2020-06-09 | 2020-06-11 | 25,748 | — | $0 | 51,343 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-02-11 | 2020-02-12 | 26,911 | — | $0 | 39,063 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2020-02-11 | 2020-02-12 | 1,185 | — | $0 | 234,815 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-02-11 | 2020-02-12 | 26,911 | $4.80 | $129.2K | 54,137 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2020-02-11 | 2020-02-12 | 1,185 | $6.15 | $7.3K | 27,226 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2020-01-30 | 2020-02-03 | 393,950 | — | $0 | 393,950 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2019-06-10 | 2019-06-12 | 19,423 | — | $0 | 25,595 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2019-01-22 | 2019-01-24 | 220,000 | — | $0 | 220,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2019-01-02 | 2019-07-18 | 1,500 | — | $0 | 1,500 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2018-11-06 | 2018-11-09 | 26,041 | — | $0 | 65,974 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2018-11-06 | 2018-11-09 | 26,041 | $4.80 | $125.0K | 59,026 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2018-06-12 | 2018-06-14 | 5,822 | — | $0 | 6,172 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2018-05-31 | 2018-06-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 275,000 | — | $0 | 275,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2018-01-02 | 2018-03-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2017-08-22 | 2017-08-23 | 27,985 | — | $0 | 92,015 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2017-08-22 | 2017-08-23 | 27,985 | $4.80 | $134.3K | 32,985 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2017-06-12 | 2017-06-14 | 7,604 | — | $0 | 7,604 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2017-04-21 | 2017-04-24 | 5,000 | — | $0 | 120,000 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2017-04-21 | 2017-04-24 | 5,000 | $4.80 | $24.0K | 5,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2017-01-23 | 2017-01-25 | 236,000 | — | $0 | 236,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2016-11-14 | 2016-11-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2016-11-02 | 2016-11-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2016-01-29 | 2016-02-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2016-01-29 | 2016-02-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2015-12-16 | 2015-12-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2015-09-08 | 2015-09-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award | 2015-04-01 | 2015-04-02 | 3,000 | — | $0 | 3,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2014-12-15 | 2014-12-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2013-12-19 | 2013-12-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2013-10-18 | 2013-10-21 | 40,000 | — | $0 | 40,000 | SEC↗ |